Visby Medical Raises over $100 Million in Series E Financing
Investment will accelerate the development of revolutionary rapid, single-use PCR diagnostic technology for home use
Day: March 1, 2022
Visby Medical™ Receives FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test Read more
